D. Lau
University of California
Davis Cancer Center
and Veterans Affairs Northern California Health Care System
Sacramento 95817
USA
Name/email consistency: low
- Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial. Lau, D., Leigh, B., Gandara, D., Edelman, M., Morgan, R., Israel, V., Lara, P., Wilder, R., Ryu, J., Doroshow, J. J. Clin. Oncol. (2001)